GSK recalls 600,000 Ventolin Inhalers from US

GSK recalls 600,000 Ventolin Inhalers from US

Multinational pharmaceutical company, GlaxoSmithKline (GSK) has announced the recall of over 590,000 Salbutamol  (Ventolin) inhalers from the US market, saying there could be issues with the delivery technique.

The recall is for three lots of Ventolin HFA 200D inhalers with lot numbers 6ZP0003, 6ZP9944 and 6ZP9848.

The inhalers, according to reports,  have been distributed to hospitals, pharmacies, retailers and wholesalers in the United States.

“There is attainable risk that the affected inhalers could potentially not deliver the stated number of actuations,” according to GSK spokesman Juan Carlos Molina. “We continue to investigate the situation in order to identify the root lead to and implement appropriate corrective and preventative actions.”

The recall is not directed at individuals, but those with inhalers from the recalled lots have been advised to contact the company.

About author

You might also like

Rape: NAWOJ urges FG to expedite action

Comrade Adeola Ekine Chairperson, NAWOJ Lagos   The Nigerian Association of Women Journalists, NAWOJ, has called on the federal government to expedite action on rape to end the menace.  

DevComs calls for adequate protection for women, girls against COVID-19

As Nigeria joins the rest of the world to mark this year’s World Population Day, WPD, Development Communications Network, DevComs, has called on the federal government to provide adequate protection

WORLD HEALTH 0 Comments

New hope with Ebola drug trial

By the time Kambale Kombi Vianey arrived at the Ebola Treatment Centre (ETC) in Beni in the Democratic Republic of the Congo information late November, he was at death’s door.

0 Comments

No Comments Yet!

You can be first to comment this post!

Leave a Reply